Ibex Investors’s DexCom DXCM Stock Holding History

Ibex Investors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-7,668	Closed	-$230K	–	79
2018 Q4	$230K	Buy	7,668 +1,772	+30%	+$56.2K	0.04%	75
2018 Q3	$211K	Sell	5,896 -10,344	-64%	-$321K	0.12%	103
2018 Q2	$386K	Buy	+16,240	New	+$344K	0.22%	113

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Ibex Investors's DXCM Position: Q1 2019 in Review

Ibex Investors sold out of DexCom (DXCM) in Q1 2019, closing a stake of 7,668 shares — an estimated $230K sold.

Ibex Investors first reported a position in DXCM in Q2 2018 and held it in 3 quarters. The position peaked at $386K in Q2 2018. 457 funds tracked by Wall St. Rank hold DXCM as of Q1 2019.

Ibex Investors reported no remaining DexCom position as of Q1 2019 after selling out during the quarter.
Ibex Investors sold 7,668 DexCom shares in Q1 2019, an estimated $230K.
Ibex Investors first reported a position in DexCom in Q2 2018 and held it in 3 quarters.
Ibex Investors's DexCom position peaked at $386K in Q2 2018.
457 funds tracked by Wall St. Rank held DexCom as of Q1 2019.

Based on Ibex Investors's 13F filing for Q1 2019, filed 7 May 2019.